MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease-Reference-Cited by-同舟云学术

MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease

Published:2021-03 Issue:3 Volume:23 Page:203-210
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Brault Julie,Meis Ronald J.,Li Linhong,Bello Ezekiel,Liu Taylor,Sweeney Colin L.,Koontz Sherry M.,Dowdell Kennichi,Theobald Narda,Lee Janet,Allen Cornell,Clark Aaron B.,Ravell Juan C.,Lenardo Michael J.,Dahl Gary A.,Malech Harry L.,De Ravin Suk See

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference51 articles.

1. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus;Li;Blood,2014

2. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect;Ravell;Curr Opin Pediatr,2014

3. The role of MAGT1 in genetic syndromes;Trapani;Magnes Res,2015

4. Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection;Brigida;J Clin Immunol,2017

5. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease;Dhalla;J Clin Immunol,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum;Journal of Clinical Immunology;2024-06-19

2. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review;Frontiers in Immunology;2024-03-14

3. Increased RNA editing sites revealed as potential novel biomarkers for diagnosis in primary Sjögren's syndrome;Journal of Autoimmunity;2023-07

4. Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease;Journal of Allergy and Clinical Immunology;2023-06

5. Further Delineation of the Spectrum of XMEN Disease in Six Chinese Pediatric Patients;Frontiers in Genetics;2022-01-25